Market Cap ₹898 Cr.
Stock P/E 13.5
P/B 2.7
Current Price ₹712
Book Value ₹ 260.8
Face Value 10
52W High ₹905.9
Dividend Yield 0.7%
52W Low ₹ 341.1
Pondy Oxides and Chemicals Ltd is an primarily India-based organization, which is engaged within the commercial enterprise of lead metallic and alloy. The Company produces lead and lead alloys, and poly-vinyl chloride (PVC) components that are supplied to numerous clients, including battery manufacturers, chemical manufacturers and PVC extruded and molded merchandise. Its divisions include PVC stabilizer division and Smelter department. Its merchandise consist of Antimony Alloys; Master Alloys; Tin Alloys; Babbit Alloys, Lead; Lead Alloys, Calcium Alloys and PVC additives. It offers products beneath PVC components, such as Di Basic Lead Phthalate and Tri Basic Lead Sulphate. Its one pack products encompass POCL-2900, POCL-10F, POCL-3300, POCL-4500, lubricated one pack stabilizer POCL 2000, POCL-5, POCL-315 and POCL-3500. Its stearates include barium stearate, lead stearate, calcium stearate, and zinc stearate, . Its liquids consist of Pondystab 111 and Pondystab 999. Its lubricants encompass PL-100 and PL-25.
Price goes above X
Price falls below X
PE goes above X
PE falls below X
₹ | |
| #(Fig in Cr.) | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
|---|---|---|---|---|---|---|
| Net Sales | 301 | 374 | 437 | 325 | 397 | 457 |
| Other Income | 1 | 0 | 1 | 1 | 1 | -1 |
| Total Income | 303 | 374 | 438 | 326 | 398 | 456 |
| Total Expenditure | 284 | 356 | 414 | 313 | 381 | 433 |
| Operating Profit | 19 | 19 | 25 | 13 | 17 | 24 |
| Interest | 1 | 1 | 3 | 4 | 5 | 5 |
| Depreciation | 2 | 3 | 4 | 3 | 3 | 4 |
| Exceptional Income / Expenses | 0 | 0 | 29 | 0 | 0 | 0 |
| Profit Before Tax | 16 | 15 | 47 | 6 | 9 | 15 |
| Provision for Tax | 4 | 4 | 5 | 2 | 3 | 5 |
| Profit After Tax | 12 | 11 | 41 | 4 | 6 | 10 |
| Adjustments | 0 | 0 | -0 | 0 | 0 | 0 |
| Profit After Adjustments | 12 | 11 | 41 | 4 | 6 | 10 |
| Adjusted Earnings Per Share | 10.1 | 9.3 | 35.6 | 3.5 | 4.9 | 8.7 |
| #(Fig in Cr.) | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2023 | TTM |
|---|---|---|---|---|---|---|
| Net Sales | 323 | 309 | 359 | 457 | 1476 | 1616 |
| Other Income | 2 | 2 | 4 | 1 | 4 | 2 |
| Total Income | 325 | 311 | 362 | 459 | 1480 | 1618 |
| Total Expenditure | 303 | 299 | 348 | 444 | 1398 | 1541 |
| Operating Profit | 21 | 12 | 14 | 15 | 83 | 79 |
| Interest | 8 | 6 | 8 | 8 | 8 | 17 |
| Depreciation | 3 | 3 | 2 | 2 | 11 | 14 |
| Exceptional Income / Expenses | 0 | 1 | 1 | -0 | 29 | 29 |
| Profit Before Tax | 11 | 4 | 5 | 4 | 92 | 77 |
| Provision for Tax | 4 | 1 | 1 | 1 | 17 | 15 |
| Profit After Tax | 7 | 3 | 3 | 3 | 76 | 61 |
| Adjustments | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit After Adjustments | 7 | 3 | 3 | 3 | 76 | 61 |
| Adjusted Earnings Per Share | 3.7 | 1.3 | 1.5 | 1.3 | 65 | 52.7 |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Sales CAGR | 223% | 68% | 0% | 0% |
| Operating Profit CAGR | 453% | 91% | 0% | 0% |
| PAT CAGR | 2433% | 194% | 0% | 0% |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Share Price CAGR | 99% | 80% | 35% | 50% |
| ROE Average | 50% | 22% | 20% | 20% |
| ROCE Average | 38% | 21% | 19% | 19% |
| #(Fig in Cr.) | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2023 |
|---|---|---|---|---|---|
| Shareholder's Funds | 35 | 36 | 38 | 40 | 265 |
| Minority's Interest | 3 | 0 | 0 | 0 | 0 |
| Borrowings | 2 | 7 | 8 | 10 | 6 |
| Other Non-Current Liabilities | 1 | 1 | 2 | 2 | 5 |
| Total Current Liabilities | 82 | 58 | 93 | 90 | 194 |
| Total Liabilities | 123 | 102 | 141 | 141 | 469 |
| Fixed Assets | 26 | 21 | 23 | 22 | 148 |
| Other Non-Current Assets | 2 | 2 | 2 | 4 | 19 |
| Total Current Assets | 95 | 79 | 116 | 115 | 301 |
| Total Assets | 123 | 102 | 141 | 141 | 469 |
| #(Fig in Cr.) | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2023 |
|---|---|---|---|---|---|
| Opening Cash & Cash Equivalents | 4 | 8 | 12 | 13 | 1 |
| Cash Flow from Operating Activities | 18 | 22 | -17 | 9 | 78 |
| Cash Flow from Investing Activities | -7 | -4 | -2 | -2 | -109 |
| Cash Flow from Financing Activities | -7 | -13 | 20 | -13 | 30 |
| Net Cash Inflow / Outflow | 3 | 4 | 1 | -6 | -0 |
| Closing Cash & Cash Equivalent | 8 | 12 | 13 | 7 | 1 |
| # | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2023 |
|---|---|---|---|---|---|
| Earnings Per Share (Rs) | 3.73 | 1.31 | 1.46 | 1.31 | 65.05 |
| CEPS(Rs) | 5.01 | 2.59 | 2.44 | 2.26 | 74.59 |
| DPS(Rs) | 0.7 | 0.5 | 1 | 1 | 5 |
| Book NAV/Share(Rs) | 17.47 | 16.18 | 16.99 | 17.75 | 227.75 |
| Core EBITDA Margin(%) | 5.75 | 3.32 | 2.68 | 2.76 | 5.31 |
| EBIT Margin(%) | 5.54 | 3.1 | 3.2 | 2.58 | 6.82 |
| Pre Tax Margin(%) | 3.31 | 1.36 | 1.22 | 0.88 | 6.26 |
| PAT Margin (%) | 2.21 | 0.9 | 0.83 | 0.58 | 5.12 |
| Cash Profit Margin (%) | 2.97 | 1.78 | 1.39 | 1.01 | 5.87 |
| ROA(%) | 6.55 | 2.6 | 2.68 | 2.07 | 24.78 |
| ROE(%) | 23.22 | 8.24 | 8.82 | 7.53 | 49.69 |
| ROCE(%) | 20.37 | 11.11 | 12.51 | 11.26 | 38.24 |
| Receivable days | 36.04 | 33.2 | 35.73 | 37.06 | 18.56 |
| Inventory Days | 30.19 | 35.06 | 30.68 | 27.36 | 25.05 |
| Payable days | 9.92 | 12.43 | 15.1 | 15.91 | 3.77 |
| PER(x) | 4.19 | 9.39 | 7.47 | 7.73 | 4.56 |
| Price/Book(x) | 0.89 | 0.76 | 0.64 | 0.57 | 1.3 |
| Dividend Yield(%) | 4.48 | 4.05 | 4.58 | 4.95 | 1.68 |
| EV/Net Sales(x) | 0.26 | 0.21 | 0.24 | 0.2 | 0.33 |
| EV/Core EBITDA(x) | 3.9 | 5.31 | 6.17 | 6.05 | 5.94 |
| Net Sales Growth(%) | 40.32 | -4.14 | 15.96 | 27.49 | 222.76 |
| EBIT Growth(%) | -14.04 | -46.47 | 24.43 | 2.84 | 682.23 |
| PAT Growth(%) | -38.98 | -60.87 | 11.26 | -10.59 | 2493.22 |
| EPS Growth(%) | -38.98 | -64.74 | 11.26 | -10.62 | 4875.51 |
| Debt/Equity(x) | 1.7 | 1.39 | 2 | 1.9 | 0.56 |
| Current Ratio(x) | 1.16 | 1.36 | 1.24 | 1.29 | 1.55 |
| Quick Ratio(x) | 0.8 | 0.8 | 0.89 | 0.82 | 0.78 |
| Interest Cover(x) | 2.48 | 1.79 | 1.61 | 1.52 | 12.19 |
| Total Debt/Mcap(x) | 1.89 | 1.82 | 3.12 | 3.34 | 0.43 |
| # | Dec 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 48.74 | 48.74 | 48.89 | 48.86 | 48.86 | 48.88 | 48.88 | 48.88 | 48.89 | 48.9 |
| FII | 0 | 0 | 0 | 1.03 | 0.12 | 0 | 0.13 | 0.01 | 0.18 | 0.22 |
| DII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Public | 51.26 | 51.26 | 51.11 | 50.12 | 51.03 | 51.12 | 50.98 | 51.1 | 50.93 | 50.89 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| # | Dec 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 0.28 | 0.28 | 0.28 | 0.28 | 0.57 | 0.57 | 0.57 | 0.57 | 0.57 | 0.57 |
| FII | 0 | 0 | 0 | 0.01 | 0 | 0 | 0 | 0 | 0 | 0 |
| DII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Public | 0.3 | 0.3 | 0.3 | 0.29 | 0.59 | 0.59 | 0.59 | 0.59 | 0.59 | 0.59 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 0.58 | 0.58 | 0.58 | 0.58 | 1.16 | 1.16 | 1.16 | 1.16 | 1.16 | 1.16 |
Pros
Cons
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
| Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
|---|
| Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
|---|
| Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
|---|
| Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
|---|
| Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
|---|
You May Also Know About
